Skip to main content
Premium Trial:

Request an Annual Quote

ProteoMonitor s IP Roundup: Recent Patents of Interest in Proteomics: Dec 2, 2005

Premium

US Patent No. 6,963,807. Automated identification of peptides. Inventors: Robert Townsend, Andrew Robinson. Assignee: Oxford Glycosciences [now Oxford Genome Sciences].

This invention relates to computer-mediated methods for automated interpretation on data obtained by mass spectrometry. The method identifies a corresponding peptide sequence if it is present in a peptide database, without the need for a skilled observer to choose from amongst a list of possible matches. The method also permits mapping of mass spectral data to sequences in peptide or nucleotide databases for unambiguous identification of exons; determining a correct reading frame; identifying artifacts and errors in sequences; identifying mutations and polymorphisms; identifying post-translational modifications; and identifying exon-intron boundaries.


US Patent No. 6,969,757. Differential labeling for quantitative analysis of complex protein mixtures. Inventors: Paul Haynes, Jing Wei, John Yates, Nancy Andon. Assignee: Syngenta Participations.

This inventions relates to a method for simultaneously identifying and determining the levels of expression of cysteine-containing proteins in normal and perturbed cells.


US Patent No. 6,969,614. Methods for the isolation and analysis of cellular protein content. Inventors: Lance Liotta, Nicole Simone, Michael Emmert-Buck, Emmanuel Petricoin. Assignee: The United States of America as represented by the Department of Health and Human Services.

This invention describes devices and methods for performing protein analysis on laser capture microdissected cells. In addition to permitting direct comparison of qualitative and quantitative protein content of tumor cells and normal cells from the same tissue sample, the methods also allow for investigation of protein characteristics of tumor cells, such as binding ability, amino acid sequence, and differential expression of proteins in particular cell populations in response to drug treatment. The methods also provide, through the use of protein fingerprinting, a rapid and reliable way to identify the source tissue of a tumor metastasis.


US Patent No. 6,969,452. Two-dimensional protein separations using chromatofocusing and multiplexed capillary gel electrophoresis. Inventors: Yan He, Ho-Ming Pang, Siquan Luo, Futian Han. Assignee: Combisep.

This invention discloses a two-dimensional protein separation method. The method is based on separating a protein sample by chromatofocusing into a number of aliquots, then loading each aliquot into a separate capillary tube, and separating each aliquot by multiplexed capillary electrophoresis to produce a two-dimensional array of separated proteins.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.